NVST
Price
$25.30Alerts
Change
-$0.54 (-2.09%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
4.04B
90 days until earnings call
Intraday BUY SELL Signals
VREX
Price
$18.39Alerts
Change
-$0.06 (-0.33%)
Updated
Nov 11 closing price
Capitalization
783.03M
5 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NVST vs VREX

NVST vs VREX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NVST vs. VREX commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVST is a Hold and VREX is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for NVST with price predictions
Nov 11, 2026

Aroon Indicator for NVST shows an upward move is likely

NVST's Aroon Indicator triggered a bullish signal on November 11, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 155 similar instances where the Aroon Indicator showed a similar pattern. In 105 of the 155 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on NVST as a result. In 71 of 107 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.

NVST moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NVST crossed bullishly above the 50-day moving average on November 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Following a +4.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where NVST advanced for three days, in 171 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

Bearish Trend Analysis

The 10-day RSI Indicator for NVST moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In 18 of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 63 cases where NVST's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.

The 50-day moving average for NVST moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

NVST broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. NVST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.314) is normal, around the industry mean (4.964). P/E Ratio (42.661) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.451) is also within normal values, averaging (56.876).

The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for VREX with price predictions
Nov 11, 2026

VREX in +0.54% Uptrend, advancing for three consecutive days on November 03, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where VREX advanced for three days, in 195 of 310 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VREX as a result. In 64 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 67%.

VREX moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VREX crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VREX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

VREX broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VREX entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. VREX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 84 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.577) is normal, around the industry mean (4.142). P/E Ratio (34.148) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (4.979) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.903) is also within normal values, averaging (40.124).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VREX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
NVST vs VREX: Fundamental Ratings
NVST
VREX
OUTLOOK RATING
1..100
4262
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
90
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8784
PRICE GROWTH RATING
1..100
4538
P/E GROWTH RATING
1..100
967
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (64) in the null industry is in the same range as VREX (90) in the Medical Specialties industry. This means that NVST’s stock grew similarly to VREX’s over the last 12 months.

NVST's Profit vs Risk Rating (100) in the null industry is in the same range as VREX (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to VREX’s over the last 12 months.

VREX's SMR Rating (84) in the Medical Specialties industry is in the same range as NVST (87) in the null industry. This means that VREX’s stock grew similarly to NVST’s over the last 12 months.

VREX's Price Growth Rating (38) in the Medical Specialties industry is in the same range as NVST (45) in the null industry. This means that VREX’s stock grew similarly to NVST’s over the last 12 months.

VREX's P/E Growth Rating (7) in the Medical Specialties industry is significantly better than the same rating for NVST (96) in the null industry. This means that VREX’s stock grew significantly faster than NVST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSTVREX
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
58%
Momentum
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
67%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 9 days ago
63%
Declines
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 7 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
67%
Aroon
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
75%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (NVST: $25.32 vs. VREX: $18.39)
Brand notoriety: NVST and VREX are both not notable
NVST represents the Pharmaceuticals: Other, while VREX is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: NVST: 74% vs. VREX: 74%
Market capitalization -- NVST: $4.04B vs. VREX: $783.03M
NVST [@Pharmaceuticals: Other] is valued at $4.04B. VREX’s [@Medical/Nursing Services] market capitalization is $783.03M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVST’s FA Score shows that 0 FA rating(s) are green while VREX’s FA Score has 1 green FA rating(s).

  • NVST’s FA Score: 0 green, 5 red.
  • VREX’s FA Score: 1 green, 4 red.
According to our system of comparison, VREX is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVST’s TA Score shows that 5 TA indicator(s) are bullish while VREX’s TA Score has 2 bullish TA indicator(s).

  • NVST’s TA Score: 5 bullish, 5 bearish.
  • VREX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, NVST is a better buy in the short-term than VREX.

Price Growth

NVST (@Pharmaceuticals: Other) experienced а -6.88% price change this week, while VREX (@Medical/Nursing Services) price change was -0.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.07%. For the same industry, the average monthly price growth was +6.43%, and the average quarterly price growth was +22.77%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.

Reported Earning Dates

NVST is expected to report earnings on Feb 10, 2027.

VREX is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+2.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-2.76% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been closely correlated with ALGN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVST jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
-2.01%
ALGN - NVST
70%
Closely correlated
-1.25%
XRAY - NVST
63%
Loosely correlated
+0.62%
BIO - NVST
57%
Loosely correlated
-0.12%
A - NVST
55%
Loosely correlated
-0.52%
MTD - NVST
52%
Loosely correlated
-0.14%
More

VREX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VREX has been loosely correlated with NVST. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if VREX jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VREX
1D Price
Change %
VREX100%
-0.33%
NVST - VREX
51%
Loosely correlated
-2.01%
ATR - VREX
47%
Loosely correlated
-0.72%
A - VREX
47%
Loosely correlated
-0.52%
ISRG - VREX
43%
Loosely correlated
-0.11%
DHR - VREX
43%
Loosely correlated
-0.34%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OLMA8.040.77
+10.59%
Olema Pharmaceuticals
GRO1.860.01
+0.54%
Brazil Potash Corp
KBH50.04-0.43
-0.85%
KB Home
ORKT0.99-0.01
-0.97%
Orangekloud Technology Inc
RCI33.04-0.72
-2.13%
Rogers Communications